Author

Jingxuan Liu

St. Luke's University Health NetworkORCID 0009-0007-9873-7201Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Brian S. SheridaniD· 1 shared Hong QiniD· 1 shared Nancy C. ReichiD· 1 shared Stephen D’AmicoiD· 1 shared Varvara KirilloviD· 1 shared Xinyuan LeiiD· 1 shared Zhijuan QiuiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Brian S. SheridanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyEMBO ReportsPeer-reviewedAug 26, 2025

STAT3 Sustains Tumorigenicity Following Mutant KRAS Ablation

Stephen D’Amico, Varvara Kirillov, Jingxuan Liu…·Nancy C. Reich

This study shows that STAT3 sustains tumorigenicity in KRAS-ablated pancreatic cancer cells, highlighting its role in maintaining malignant identity and suggesting it as a therapeutic target.

2 citations

mousebulk RNA-seq

𝕏 PostBluesky